How big is the Global Minimal Residual Disease Market?

The Global Minimal Residual Disease Market size is expected to reach USD 1.90 billion in 2024 and grow at a CAGR of 12.88% to reach USD 3.49 billion by 2029. Read More

What is the current Global Minimal Residual Disease Market size?

In 2024, the Global Minimal Residual Disease Market size is expected to reach USD 1.90 billion. Read More

Who are the key players in Global Minimal Residual Disease Market?

Adaptive Biotechnologies, Bristol-Myers Squibb Company, Kite Pharma, Natera and Amgen Inc. are the major companies operating in the Global Minimal Residual Disease Market. Read More

Which is the fastest growing region in Global Minimal Residual Disease Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Minimal Residual Disease Market?

In 2024, the North America accounts for the largest market share in Global Minimal Residual Disease Market. Read More

What years does this Global Minimal Residual Disease Market cover, and what was the market size in 2023?

In 2023, the Global Minimal Residual Disease Market size was estimated at USD 1.68 billion. The report covers the Global Minimal Residual Disease Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Minimal Residual Disease Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Minimal Residual Disease Companies

This report lists the top Global Minimal Residual Disease companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Minimal Residual Disease industry.